Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Cunningham

Showing results (411-420 of 621) with videos related to

Pageof 63
Sort By:
Cancers|October 17, 2019
Outcomes of Patients with Early Onset Colorectal Cancer Treated in a UK Specialist Cancer CenterAlexandros Georgiou, Shelize Khakoo, Penelope Edwards, et al.
Cancer Immunology Research|March 20, 2026
Co-expression of IL15 promotes effector differentiation and sustained proliferative capacity in ALPPL2-specific human CAR T cellsDavid Cunningham, Junquan Liu, Inci Cevher Zeytin, et al.
Annals of Surgical Oncology|October 18, 2022
The Cancer Hub Approach for Upper Gastrointestinal Surgery During COVID-19 Pandemic: Outcomes from a UK Cancer CentreJoseph P Doyle, Pranav H Patel, Sophie L F Doran, et al.
Bone Marrow Transplantation|October 6, 2021
Can pre-transplant 18F-choline positron emission tomography predict relapse following autologous stem cell transplantation in primary central nervous system lymphoma?Thomas Millard, Fatin Sammour, Chloe Anthias, et al.
Applied Health Economics and Health Policy|October 22, 2016
Ethical Hurdles in the Prioritization of Oncology CareFolkert de Groot, Stefano Capri, Jean-Claude Castanier, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 5, 2011
Second cancer risk after chemotherapy for Hodgkin's lymphoma: a collaborative British cohort studyAnthony J Swerdlow, Craig D Higgins, Paul Smith, et al.
Molecular Cancer Therapeutics|July 3, 2019
Differences in Signaling Patterns on PI3K Inhibition Reveal Context Specificity in <i>KRAS</i>-Mutant CancersAdam Stewart, Elizabeth A Coker, Sebastian Pölsterl, et al.
Oncotarget|February 11, 2016
miR-21 expression and clinical outcome in locally advanced pancreatic cancer: exploratory analysis of the pancreatic cancer Erbitux, radiotherapy and UFT (PERU) trialKhurum Khan, David Cunningham, Clare Peckitt, et al.
Heart (British Cardiac Society)|July 24, 2014
Device-dependent association between paravalvar aortic regurgitation and outcome after TAVIRafal Dworakowski, Olaf Wendler, Brian Halliday, et al.
British Journal of Haematology|April 29, 2020
LyRIC indeterminate response and Immune-mediated pseudoprogression of diffuse large B-cell lymphoma following polatuzumab-based salvage therapyAlexander T J Lee, Ayoma D Attygale, Rajaei K Sharma, et al.
Pageof 63

Showing results (411-420 of 621) with videos related to

Sort By:
Pageof 63
Cancers|October 17, 2019
Outcomes of Patients with Early Onset Colorectal Cancer Treated in a UK Specialist Cancer CenterAlexandros Georgiou, Shelize Khakoo, Penelope Edwards, et al.
Cancer Immunology Research|March 20, 2026
Co-expression of IL15 promotes effector differentiation and sustained proliferative capacity in ALPPL2-specific human CAR T cellsDavid Cunningham, Junquan Liu, Inci Cevher Zeytin, et al.
Annals of Surgical Oncology|October 18, 2022
The Cancer Hub Approach for Upper Gastrointestinal Surgery During COVID-19 Pandemic: Outcomes from a UK Cancer CentreJoseph P Doyle, Pranav H Patel, Sophie L F Doran, et al.
Bone Marrow Transplantation|October 6, 2021
Can pre-transplant 18F-choline positron emission tomography predict relapse following autologous stem cell transplantation in primary central nervous system lymphoma?Thomas Millard, Fatin Sammour, Chloe Anthias, et al.
Applied Health Economics and Health Policy|October 22, 2016
Ethical Hurdles in the Prioritization of Oncology CareFolkert de Groot, Stefano Capri, Jean-Claude Castanier, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 5, 2011
Second cancer risk after chemotherapy for Hodgkin's lymphoma: a collaborative British cohort studyAnthony J Swerdlow, Craig D Higgins, Paul Smith, et al.
Molecular Cancer Therapeutics|July 3, 2019
Differences in Signaling Patterns on PI3K Inhibition Reveal Context Specificity in <i>KRAS</i>-Mutant CancersAdam Stewart, Elizabeth A Coker, Sebastian Pölsterl, et al.
Oncotarget|February 11, 2016
miR-21 expression and clinical outcome in locally advanced pancreatic cancer: exploratory analysis of the pancreatic cancer Erbitux, radiotherapy and UFT (PERU) trialKhurum Khan, David Cunningham, Clare Peckitt, et al.
Heart (British Cardiac Society)|July 24, 2014
Device-dependent association between paravalvar aortic regurgitation and outcome after TAVIRafal Dworakowski, Olaf Wendler, Brian Halliday, et al.
British Journal of Haematology|April 29, 2020
LyRIC indeterminate response and Immune-mediated pseudoprogression of diffuse large B-cell lymphoma following polatuzumab-based salvage therapyAlexander T J Lee, Ayoma D Attygale, Rajaei K Sharma, et al.
Pageof 63